{
    "clinical_study": {
        "@rank": "157904", 
        "acronym": "acute asthma", 
        "biospec_descr": {
            "textblock": "Samples of blood will be secured in the Division of Allergy/Immunology at the University of\n      South Florida, Joy McCann Culverhouse Airways Disease Center. All samples will be\n      appropriately coded to maintain confidentiality. Blood specimens will be held at minus 20\n      degrees Celsius. GENETICS SAMPLES ARE OPTIONAL"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The investigators hypothesize that there is a statistically significant decrease of\n      Natriuretic Hormone Peptides  (NHPs) in subjects with asthma exacerbation compared to levels\n      following treatment of an exacerbation of asthma."
        }, 
        "brief_title": "Measurement of Natriuretic Hormone Peptides in Exacerbation of Asthma", 
        "completion_date": {
            "#text": "February 2011", 
            "@type": "Actual"
        }, 
        "condition": "ASTHMA", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "detailed_description": {
            "textblock": "Overall Study Design\n\n        1. Measurement of Natriuretic Hormone Peptides  in individuals suffering from exacerbation\n           of asthma.\n\n        2. Measurement of  Natriuretic Hormone Peptides 5-7 days after initiation of treatment of\n           exacerbation of asthma.\n\n        3. Measurement of  Natriuretic Hormone Peptides 10-14 days after initiation of treatment\n           of exacerbation of asthma.\n\n      3 comparisons of Natriuretic Hormone Peptides levels will be made:\n\n        1. Exacerbation compared to 5-7 days after initiation of treatment\n\n        2. Exacerbation compared to 10-14 days after initiation of treatment\n\n        3. 5-7 days after initiation of treatment compared to 10-14 days after initiation of\n           treatment.\n\n      Samples of blood will be secured in the Division of Allergy/Immunology at the University of\n      South Florida, Joy McCann Culverhouse Airways Disease Center. All samples will be\n      appropriately coded to maintain confidentiality. Blood specimens will be held at minus 20\n      degrees Celsius."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Both genders, age 18-85.\n\n          -  Females who are pregnant or lactating are not eligible.\n\n          -  Read and comprehend English.\n\n          -  Ability to give informed consent.\n\n          -  Seen in the outpatient setting at one of the clinic.\n\n          -  The subject must have a history of physician diagnosed asthma for at least 1 year and\n             must have an exacerbation of asthma for entry into the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The Asthma Control Test score of less than 18.\n\n        Asthma control test consists of five questions, scored 1-5 each."
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "August 5, 2010", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01690793", 
            "org_study_id": "acute asthma"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Hormones", 
                "Natriuretic Agents"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "ASTHMA", 
            "ACUTE EXACERBATION OF ASTHMA"
        ], 
        "lastchanged_date": "September 18, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Tampa", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "33613"
                }, 
                "name": "Usf Asthma Allergy and Immunology Cru"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Measurement of Natriuretic Hormone Peptides in Exacerbation of Asthma", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2010", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "The measurement of NHPs after treatment of an exacerbation of asthma", 
            "safety_issue": "No", 
            "time_frame": "14 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01690793"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of South Florida", 
            "investigator_full_name": "Richard Lockey", 
            "investigator_title": "prinicpal investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of South Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of South Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2009", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}